{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:42:40Z","timestamp":1780735360262,"version":"3.54.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Patients with heart failure often have multiple cardiovascular risk factors (CVRFs) and comorbidities (CMBs). We evaluated the impact of additive CMB and CVRF on heart failure prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We retrospectively analyzed ambulatory patients with systolic dysfunction between January 2012 and May 2018. Follow-up was until January 2021. The endpoint was all-cause death. CVRF analyzed arterial hypertension, diabetes mellitus, and smoking. CMB evaluated coronary artery disease, noncoronary atherosclerotic disease, respiratory disease, dementia, anemia, chronic kidney disease, inflammatory\/autoimmune disease, active cancer, and atrial fibrillation. Classification according to the number of CVRFs and\/or CMBs is &lt;2 and \u22652. The independent prognostic impact of CVRF\/CMB burden was assessed with multivariate Cox regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Most patients had \u22652 CMBs (67.9%). Regarding CVRF, 14.9% presented none, 40.2% had 1, and 32.1% had 2. During a median 49-month follow-up, 419 (49.1%) patients died. Mortality was higher among patients with \u22652 CVRFs (56.1 versus 43.4% in those with &lt;2) and in those with \u22652 CMBs (57.7 versus 31.0%). While patients with 1 CMB had similar mortality than those with none. Patients with \u22652 CMBs had higher long-term mortality risk: hazard ratio (HR), 2.47 (95% CI, 1.95\u20133.14). In patients with \u22652CVRFs, the HR of dying is 1.39 (95% CI, 1.14\u20131.70). When taken together, there was a clear survival disadvantage for patients with \u22652 CVRFs\/CMBs\u2014adjusted HR, 2.20 (95% CI, 1.45\u20133.34).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The presence of only 2 CVRFs\/CMBs more than doubles the patients\u00b4 risk of dying. CVRF and CMB should be assessed as part of routine patient management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/hpc.0000000000000368","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T21:01:21Z","timestamp":1732309281000},"page":"189-195","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Even a Low Comorbidity Burden Predicts Poor Outcomes in Chronic Heart Failure"],"prefix":"10.1097","volume":"23","author":[{"given":"Catarina","family":"Elias","sequence":"first","affiliation":[{"name":"the Servi\u00e7o de Medicina Interna do Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"},{"name":"Heart Failure Clinic, Medicina Interna, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Neves","sequence":"additional","affiliation":[{"name":"the Servi\u00e7o de Medicina Interna do Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"},{"name":"Heart Failure Clinic, Medicina Interna, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Gouveia","sequence":"additional","affiliation":[{"name":"the Servi\u00e7o de Medicina Interna do Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"},{"name":"Heart Failure Clinic, Medicina Interna, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"Madureira","sequence":"additional","affiliation":[{"name":"the Servi\u00e7o de Medicina Interna do Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"},{"name":"Heart Failure Clinic, Medicina Interna, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Ribeirinho-Soares","sequence":"additional","affiliation":[{"name":"the Servi\u00e7o de Medicina Interna do Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"},{"name":"Heart Failure Clinic, Medicina Interna, Porto, Portugal"},{"name":"Faculdade de Medicina da Universidade do Porto, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Soares-Carreira","sequence":"additional","affiliation":[{"name":"the Servi\u00e7o de Medicina Interna do Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"},{"name":"Heart Failure Clinic, Medicina Interna, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Pereira","sequence":"additional","affiliation":[{"name":"the Servi\u00e7o de Medicina Interna do Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"},{"name":"Heart Failure Clinic, Medicina Interna, Porto, Portugal"},{"name":"Faculdade de Medicina da Universidade do Porto, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Almeida","sequence":"additional","affiliation":[{"name":"the Servi\u00e7o de Medicina Interna do Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"},{"name":"Unidade de Investiga\u00e7\u00e3o & Desenvolvimento Cardiovascular, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Louren\u00e7o","sequence":"additional","affiliation":[{"name":"the Servi\u00e7o de Medicina Interna do Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"},{"name":"Heart Failure Clinic, Medicina Interna, Porto, Portugal"},{"name":"Faculdade de Medicina da Universidade do Porto, Porto, Portugal"},{"name":"Unidade de Investiga\u00e7\u00e3o & Desenvolvimento Cardiovascular, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"R1-20250506","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/164_2017_27","article-title":"Comorbidities in heart failure.","volume":"243","author":"van der Wal","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"R2-20250506","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.30","article-title":"Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey.","volume":"16","author":"van Deursen","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"R3-20250506","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00392-019-01430-0","article-title":"Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry.","volume":"108","author":"Ergatoudes","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"R4-20250506","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s10389-020-01223-0","article-title":"Multimorbidity and multiple causes of death in heart failure.","volume":"29","author":"Haregu","year":"2021","journal-title":"J Public Health (Bangkok)"},{"key":"R5-20250506","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.amjmed.2014.08.024","article-title":"Multimorbidity in heart failure: a community perspective.","volume":"128","author":"Chamberlain","year":"2015","journal-title":"Am J Med"},{"key":"R6-20250506","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/jgs.15590","article-title":"Multimorbidity burden and adverse outcomes in a community-based cohort of adults with heart failure.","volume":"66","author":"Tisminetzky","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"R7-20250506","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.","volume":"59","author":"Ather","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R8-20250506","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2016.03.001","article-title":"Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): a multidisciplinary position statement.","volume":"212","author":"Stewart","year":"2016","journal-title":"Int J Cardiol"},{"key":"R9-20250506","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/heartjnl-2020-317833","article-title":"Association of heart failure and its comorbidities with loss of life expectancy.","volume":"107","author":"Drozd","year":"2021","journal-title":"Heart"},{"key":"R10-20250506","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-012-9370-7","article-title":"Co-morbidities in heart failure.","volume":"19","author":"van Deursen","year":"2014","journal-title":"Heart Fail Rev"},{"key":"R11-20250506","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jchf.2015.03.004","article-title":"Burden of comorbidities and functional and cognitive impairments in elderly patients at the initial diagnosis of heart failure and their impact on total mortality.","volume":"3","author":"Murad","year":"2015","journal-title":"JACC Heart Fail"},{"key":"R12-20250506","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11606-011-1930-3","article-title":"Impact of comorbidity on mortality among older persons with advanced heart failure.","volume":"27","author":"Ahluwalia","year":"2012","journal-title":"J Gen Intern Med"},{"key":"R13-20250506","doi-asserted-by":"crossref","first-page":"e033174","DOI":"10.1136\/bmjopen-2019-033174","article-title":"Multimorbidity patterns in patients with heart failure: an observational Spanish study based on electronic health records.","volume":"9","author":"Gimeno-Miguel","year":"2019","journal-title":"BMJ Open"},{"key":"R14-20250506","doi-asserted-by":"crossref","first-page":"e1002541","DOI":"10.1371\/journal.pmed.1002541","article-title":"Multimorbidity in patients with heart failure from 11 Asian regions: a prospective cohort study using the ASIAN-HF registry. Rahimi K, editor.","volume":"15","author":"Tromp","year":"2018","journal-title":"PLoS Med"},{"key":"R15-20250506","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.3399\/bjgp17X690533","article-title":"Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care.","volume":"67","author":"Baron-Franco","year":"2017","journal-title":"Br J Gen Pract"},{"key":"R16-20250506","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjmed.2010.08.017","article-title":"Trends in comorbidity, disability, and polypharmacy in heart failure.","volume":"124","author":"Wong","year":"2011","journal-title":"Am J Med"},{"key":"R17-20250506","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","article-title":"Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure.","volume":"42","author":"Braunstein","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R18-20250506","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejim.2019.10.008","article-title":"Comorbidities in chronic heart failure: an update from Italian Society of Cardiology (SIC) Working Group on Heart Failure.","volume":"71","author":"Correale","year":"2020","journal-title":"Eur J Intern Med"},{"key":"R19-20250506","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ejhf.600","article-title":"Reframing the association and significance of co-morbidities in heart failure.","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"R20-20250506","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"R21-20250506","doi-asserted-by":"crossref","first-page":"650278","DOI":"10.3389\/fcvm.2021.650278","article-title":"Metabolism and chronic inflammation: the links between chronic heart failure and comorbidities.","volume":"8","author":"Li","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R22-20250506","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijcard.2018.04.001","article-title":"Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction.","volume":"271","author":"Streng","year":"2018","journal-title":"Int J Cardiol"},{"issue":"2_suppl","key":"R23-20250506","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/2047487320957793","article-title":"Role of comorbidities in heart failure prognosis part 2: chronic kidney disease, elevated serum uric acid.","volume":"27","author":"Tedeschi","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"2_suppl","key":"R24-20250506","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/2047487320960288","article-title":"Role of comorbidities in heart failure prognosis Part I: anaemia, iron deficiency, diabetes, atrial fibrillation.","volume":"27","author":"Paolillo","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"R25-20250506","doi-asserted-by":"crossref","first-page":"e000631","DOI":"10.1161\/JAHA.113.000631","article-title":"Association of comorbidity burden with abnormal cardiac mechanics: findings from the HyperGEN study.","volume":"3","author":"Selvaraj","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R26-20250506","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/CIRCIMAGING.109.862334","article-title":"Prediction of all-cause mortality from global longitudinal speckle strain.","volume":"2","author":"Stanton","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"R27-20250506","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cardfail.2011.10.009","article-title":"Comorbidity drives mortality in newly diagnosed heart failure: a study among geriatric outpatients.","volume":"18","author":"Oudejans","year":"2012","journal-title":"J Card Fail"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T19:01:32Z","timestamp":1746558092000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0000000000000368","relation":{},"ISSN":["1535-2811"],"issn-type":[{"value":"1535-2811","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]}}}